Elanco Animal Health Inc (ELAN) SEC Filing 8-K Material Event for the period ending Wednesday, September 25, 2019

Elanco Animal Health Inc

CIK: 1739104 Ticker: ELAN

View differences made from one to another to evaluate Elanco Animal Health Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Elanco Animal Health Inc.


Assess how Elanco Animal Health Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Elanco Animal Health Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Elanco Animal Health Inc provided additional information to their SEC Filing as exhibits

Ticker: ELAN
CIK: 1739104
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-052060
Submitted to the SEC: Mon Sep 30 2019 4:43:27 PM EST
Accepted by the SEC: Mon Sep 30 2019
Period: Wednesday, September 25, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. New Costs
  3. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: